AstraZeneca says new COVID drug could guard against all variants of concern to date
CBSN
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after promising early results suggested it may work against "all known variants of concern" to date.
The company's new experimental drug, currently named AZD3152, is being tested in a trial dubbed "Supernova" with the hope of preventing symptomatic infection in people with weakened immune systems. Results from that study are on track to be out by September, an AstraZeneca spokesperson confirmed to CBS News.
That could tee up a potential emergency use authorization from the Food and Drug Administration to make the drug available by the end of the year, when another fall and winter resurgence of COVID-19 is expected.

Washington — Amid Trump administration demands for Tehran to keep the free flow of commerce in the Strait of Hormuz, U.S. officials have told CBS News that there are at least a dozen underwater mines through the vital passageway, according to current American intelligence assessments. Arden Farhi, Kathryn Watson, Caroline Linton, Aimee Picchi and Layla Ferris contributed to this report.

Washington — President Trump said early Monday that he is postponing airstrikes on Iran's power plants after "very good and productive conversations" over the last two days about reopening the Strait of Hormuz. However, Iran's foreign ministry denied any such talks. Claire Day contributed to this report. In:











